Thursday, July 25, 2024
we are hiring bened softwares
Vinkmag ad

Ticket Price Hike Approved for Kalki in Andhra Pradesh!    

Ticket Price Hike Approved for Kalki in Andhra Pradesh!    


On June 27, Nag Ashwin’s Kalki 2898 AD, starring Prabhas in the lead role, is scheduled for a worldwide grand release. The team behind the movie is working hard to wow the audience. The movie has received more attention thanks to the second trailer, which was recently released. The film’s release is anticipated with great anticipation by fans.

In Telangana, the government has permitted ticket prices for Kalki to rise. From June 27 to July 4, for a time of 8 days, ticket costs can be expanded by up to Rs. 200, with a ticket costing just Rs. 500 at certain multiplexes. From Rs., single-screen theater ticket prices have increased. 75 to Rs. 100, and Rs. 100 for regular theaters. 150 to Rs. 250. This is regarded as Prabhas’s biggest hit to date.

The public authority has likewise permitted the makers to increment ticket costs in Andhra Pradesh. Tickets can have their prices raised for a period of two weeks beginning on the 27th of this month and continuing through the 2nd of July. Additionally, Ashwini Dutt, the producer, has been permitted to raise morning show rates. Ticket costs can be expanded up to Rs. up to Rs. 125 in multiplexes 75 in theaters with only one screen. Moreover, they can now run 5 shows each day.

The film flaunts an elegant cast including Prabhas, Deepika Padukone, Amitabh Bachchan, Rana, and Disha Patani in key jobs, which has created gigantic buzz around the film. The movie is expected to have a budget of around Rs. 700 crore. It is said that Prabhas, who played the lead role, received Rs. 150 crore, while Deepika reportedly received Rs. 20 crore, Amitabh Bachchan Rs. 20 crore, Kamal Haasan Rs. 20 crore, and the Disha Patani rupees 5 crore. These figures have not yet been verified.

Vinkmag ad

Read Previous

CM Revanth Reddy Special Focus on Warangal   

Read Next

Anushka Shetty Faces Shooting Challenge Due to Rare Disease   

Leave a Reply

Your email address will not be published. Required fields are marked *